Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
about
Current updates on oxazolidinone and its significanceA Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionStructure of bacterial transcription factor SpoIIID and evidence for a novel mode of DNA bindingProgress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile.In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.Investigations of the mode of action and resistance development of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth.Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile.Efficacy of LFF571 in a hamster model of Clostridium difficile infection.In vitro and in vivo activities of DS-2969b, a novel GyrB inhibitor, against Clostridium difficile.
P2860
Q26995628-8A13A861-7CEC-43F7-99F7-5F85C4E10486Q30240264-CCC5A096-1C7F-4C84-8013-FEC29B3ED794Q33743238-39F4F9E6-EBCD-4052-A742-864246850CB6Q35044119-3E3A6192-948D-455B-B7A5-A13CB4D49A9DQ36364070-A46FAA54-4EC6-4912-8EFF-826BBB64C545Q37428616-E1656541-2F80-4888-B9AC-BEEFBBD8CC59Q37501021-28DC2F8F-5DCA-4C6A-9492-AE608F857413Q37544607-6F2FD475-F555-4F71-A01E-B8D435DB8653Q37544845-67C86A35-E4B7-4CCE-AF47-D8A43D93CF75Q40474328-D1A790CC-D464-43B6-B690-1DBDBE9FBDB2Q41596897-ED87AE3E-1CA1-4AFF-83C9-66ED7C0C9C07Q42280743-3AD714C7-3FFF-488B-A540-0D696437D7BEQ50028240-9704F469-F941-4BFF-96BB-B4BE3B82EE0E
P2860
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
@en
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
@nl
type
label
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
@en
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
@nl
prefLabel
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
@en
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
@nl
P2093
P356
P1476
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
@en
P2093
Biswajit Das
Dilip J Upadhyay
G Ram Kumar
Manoj Kumar
Pradip K Bhatnagar
Smita Singhal
Tarani K Barman
Tarun Mathur
V Samuel Raj
Vandana Kalia
P304
P356
10.1093/JAC/DKR033
P407
P577
2011-03-03T00:00:00Z